Synlab AG (SYAB.DE) XETRA
11.06
-0.02(-0.18%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
Synlab AG
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
27000
First IPO Date
April 30, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Mathieu Floreani | Chairman of the Management Board & Chief Executive Officer | 2.39M | 1967 |
| Bartholomäus Wimmer | Founder & Independent Member of the Supervisory Board | 132,000 | 1962 |
| Sami Badarani | Chief Financial Officer & Member of Management Board | 1.5M | 1963 |
| Alexander Hagen | Group Head of Commercial & Marketing | 0 | N/A |
| Anna Niedl | Head of Investor Relations | 0 | N/A |
| Santiago Valor | Chief Medical Officer | 0 | N/A |
| Luis Vieira | Group Chief Strategy Officer | 0 | N/A |
| Robert Steinwander | Group Chief Operating Officer | 0 | N/A |
| Catharina Monster | Group Chief Human Resources Officer | 0 | N/A |
| Kimberly Urdahl | Group General Counsel & Group Chief Compliance Officer | 0 | N/A |
Description
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
